April 27, 2018 12:30 UTC Accelerator Life Science Partners Launches Proniras Corporation to Support Development of Tezampanel in the Treatment of Seizure Disorders SEATTLE--( BUSINESS WIRE )-- Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for the treatment of a variety of seizure disorder
April 27, 2018
· 3 min read